Moxonidin Actavis (Moxonidine)

Moxonidine, the active ingredient in Moxonidin Actavis, is an Imidazoline receptor agonist presented as an oral tablet for prescription use. It lowers elevated blood pressure by reducing sympathetic nervous system activity and is indicated for the treatment of hypertension in adult patients. GNH USA supplies Moxonidin Actavis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moxonidin Actavis acts on central imidazoline I1 receptors to control high blood pressure. - Hypertension: reduces systolic and diastolic blood pressure in patients with primary hypertension. - Resistant hypertension: may be added when blood pressure remains uncontrolled with other agents. - Cardiovascular risk management: contributes to overall risk reduction by lowering sympathetic tone.

Moxonidine may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Dry mouth: mild to moderate sensation of oral dryness. - Dizziness: transient light‑headedness, especially after dose initiation. - Fatigue: feeling unusually tired or low in energy. - Headache: mild to moderate head pain.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure requiring medical attention. - Bradycardia: unusually slow heart rate that may need monitoring. - Allergic reaction: rash, itching, swelling, or difficulty breathing.

Before prescribing Moxonidin Actavis, clinicians should consider several safety aspects. - Monitor blood pressure: ensure adequate control and avoid excessive drops. - Assess renal function: dose adjustment may be needed in severe impairment. - Avoid abrupt discontinuation: sudden stop can cause rebound hypertension. - Caution in cardiovascular disease: monitor for hypotensive episodes. - Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Moxonidin Actavis can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Combined with other antihypertensives: risk of additive hypotension. - Concomitant clonidine: additive central sympatholytic effect may cause severe hypotension. - Use with MAO inhibitors: unpredictable blood pressure changes.

Moderate Interactions (Monitor Closely): - NSAIDs: may blunt antihypertensive response. - Diuretics: can enhance hypotensive effect. - Beta‑blockers: monitor heart rate and blood pressure closely.